Items where Author is "Hariri, A."

Article

(2024) Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance. Drug Resistance Updates. p. 15. ISSN 1368-7646

(2024) Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance. Cancer metastasis reviews. pp. 363-377. ISSN 1573-7233 (Electronic) 0167-7659 (Linking)

(2023) Artificial intelligence in detecting mandibular fractures: A review of literature. Archives of Trauma Research. pp. 102-111. ISSN 2251-953X

(2023) CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer. European Journal of Cell Biology. p. 18. ISSN 0171-9335

(2023) Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study. Frontiers in Pharmacology. p. 6.

(2023) The circadian rhythm: an influential soundtrack in the diabetes story. Frontiers in Endocrinology. p. 17. ISSN 1664-2392

(2022) Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis. CANCERS. ISSN 2072-6694 J9 - CANCERS

(2021) Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study. Iranian Journal of Pharmaceutical Research. pp. 383-389. ISSN 1735-0328 1726-6890 J9 - IRAN J PHARM RES